5-HYDROXYTRYPTOPHAN

5-HYDROXYTRYPTOPHAN was reported 53 times

5-HYDROXYTRYPTOPHAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACQUIRED CORNEAL DYSTROPHY 1 0.0263
1 GASTRIC PH INCREASED 2 0.0174
2 CORNEAL THICKENING 1 0.0147
3 AMIMIA 1 0.0091
4 MALIGNANT NEOPLASM OF SPINAL CORD 1 0.0055
5 MECONIUM ASPIRATION SYNDROME 1 0.0047
6 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 2 0.0033
7 BLADDER IRRITATION 1 0.0016
8 CHOREOATHETOSIS 1 0.0015
9 DYSCHROMATOPSIA 1 0.0012
10 HYPERVIGILANCE 1 0.0010
11 THYROTOXIC CRISIS 1 0.0009
12 MONOCYTE COUNT DECREASED 1 0.0008
13 COMPARTMENT SYNDROME 2 0.0008
14 CLONUS 2 0.0007
15 PROTHROMBIN TIME SHORTENED 1 0.0007
16 BILIARY DYSKINESIA 1 0.0006
17 FOOD INTERACTION 1 0.0006
18 MONOPARESIS 1 0.0006
19 BODY TEMPERATURE ABNORMAL 1 0.0005
20 HYPERVENTILATION 3 0.0005
21 FOETAL DISTRESS SYNDROME 1 0.0005
22 VITREOUS DETACHMENT 1 0.0005
23 CORNEAL DISORDER 1 0.0005
24 CORNEAL OEDEMA 1 0.0004
25 HAEMATOCRIT INCREASED 1 0.0004
26 EOSINOPHIL COUNT DECREASED 1 0.0004
27 RETINAL ARTERY OCCLUSION 1 0.0004
28 RED BLOOD CELL COUNT INCREASED 1 0.0004
29 KERATITIS 1 0.0003
30 RESPIRATORY RATE DECREASED 1 0.0003
31 EYE MOVEMENT DISORDER 2 0.0003
32 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
33 HYPERACUSIS 1 0.0003
34 SECOND PRIMARY MALIGNANCY 2 0.0002
35 RHEUMATIC FEVER 1 0.0002
36 BRAIN NEOPLASM MALIGNANT 1 0.0002
37 SEROTONIN SYNDROME 4 0.0002
38 PRODUCT COLOUR ISSUE 1 0.0002
39 PARTIAL SEIZURES 1 0.0002
40 MANIA 3 0.0002
41 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
42 DECREASED INTEREST 1 0.0002
43 PIGMENTATION DISORDER 1 0.0002
44 PRE-EXISTING CONDITION IMPROVED 1 0.0002
45 MULTIPLE INJURIES 1 0.0002
46 MOOD SWINGS 5 0.0002
47 UTERINE LEIOMYOMA 1 0.0001
48 HYPERTHERMIA 1 0.0001
49 ANGER 4 0.0001
50 GROIN PAIN 1 0.0001
51 CRYING 4 0.0001
52 INFLAMMATORY BOWEL DISEASE 1 0.0001
53 HYPOTONIA 1 0.0001
54 SALIVARY HYPERSECRETION 1 0.0001
55 NEUTROPHIL COUNT INCREASED 1 0.0001
56 EUPHORIC MOOD 1 0.0001
57 TENDERNESS 1 0.0001
58 WITHDRAWAL SYNDROME 4 0.0001
59 MENSTRUATION DELAYED 1 0.0001
60 SKIN INFECTION 1 0.0001
61 SCAB 1 0.0001
62 INTRAOCULAR PRESSURE INCREASED 1 0.0001
63 PULMONARY CONGESTION 1 0.0001
64 PERIPHERAL COLDNESS 1 0.0001
65 CYANOSIS 1 0.0001
66 METRORRHAGIA 1 0.0001
67 COLD SWEAT 1 0.0001
68 LYMPHOCYTE COUNT DECREASED 1 0.0001
69 GALLBLADDER DISORDER 1 0.0001
70 THIRST 1 0.0001
71 LEUKOCYTOSIS 1 0.0001
72 PHOTOPHOBIA 1 0.0001
73 SLEEP APNOEA SYNDROME 1 0.0001
74 CHOKING 1 0.0001
75 MENORRHAGIA 1 0.0001
76 SPINAL FRACTURE 1 0.0000
77 DYSKINESIA 2 0.0000
78 RHABDOMYOLYSIS 2 0.0000
79 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
80 CHROMATURIA 1 0.0000
81 INJURY 3 0.0000
82 NEURALGIA 1 0.0000
83 ABDOMINAL PAIN LOWER 1 0.0000
84 SEDATION 1 0.0000
85 BRADYCARDIA 2 0.0000
86 BREAST CANCER FEMALE 1 0.0000
87 TREATMENT NONCOMPLIANCE 2 0.0000
88 PRODUCT SUBSTITUTION ISSUE 2 0.0000
89 BLOOD POTASSIUM DECREASED 1 0.0000
90 APHASIA 1 0.0000
91 EPILEPSY 1 0.0000
92 DEEP VEIN THROMBOSIS 2 0.0000
93 VISUAL ACUITY REDUCED 1 0.0000
94 NEOPLASM PROGRESSION 1 0.0000
95 RASH MACULAR 1 0.0000
96 HYPOXIA 1 0.0000
97 PANIC ATTACK 1 0.0000
98 AGITATION 2 0.0000
99 DEPRESSION 6 0.0000
100 DISORIENTATION 1 0.0000
101 EMOTIONAL DISTRESS 3 0.0000
102 POLLAKIURIA 1 0.0000
103 VAGINAL HAEMORRHAGE 1 0.0000
104 TACHYCARDIA 2 0.0000
105 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
106 PRODUCTIVE COUGH 1 0.0000
107 MULTIPLE SCLEROSIS 1 0.0000
108 ATRIAL FIBRILLATION 2 0.0000
109 HYPOAESTHESIA 3 0.0000
110 SOMNOLENCE 4 0.0000
111 NERVOUSNESS 1 0.0000
112 ECZEMA 1 0.0000
113 DRUG INTERACTION 3 0.0000
114 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
115 INSOMNIA 5 0.0000
116 NECK PAIN 1 0.0000
117 CONVULSION 1 0.0000
118 EYE IRRITATION 1 0.0000
119 PALPITATIONS 2 0.0000
120 CHILLS 2 0.0000
121 CATARACT 1 0.0000
122 VERTIGO 1 0.0000
123 FEELING HOT 1 0.0000
124 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
125 EXPOSURE DURING PREGNANCY 1 0.0000
126 LOSS OF CONSCIOUSNESS 2 0.0000
127 AMNESIA 1 0.0000
128 BLOOD PRESSURE DECREASED 1 0.0000
129 SLEEP DISORDER 1 0.0000
130 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
131 ANXIETY 4 0.0000
132 RESPIRATORY FAILURE 1 0.0000
133 CONDITION AGGRAVATED 4 0.0000
134 BLOOD PRESSURE INCREASED 2 0.0000
135 BACK PAIN 3 0.0000
136 MUSCULOSKELETAL STIFFNESS 1 0.0000
137 SUICIDAL IDEATION 1 0.0000
138 MUSCLE SPASMS 2 0.0000
139 OROPHARYNGEAL PAIN 1 0.0000
140 CHEST PAIN 2 0.0000
141 HYPERSENSITIVITY 2 0.0000
142 PULMONARY EMBOLISM 1 0.0000
143 PAIN IN EXTREMITY 3 0.0000
144 INFLUENZA 1 0.0000
145 SEIZURE 1 0.0000
146 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
147 DECREASED APPETITE 2 0.0000
148 ABDOMINAL PAIN 2 0.0000
149 VISUAL IMPAIRMENT 1 0.0000
150 DIZZINESS 4 0.0000
151 HEADACHE 5 0.0000
152 HYPERHIDROSIS 1 0.0000
153 VISION BLURRED 1 0.0000
154 MEMORY IMPAIRMENT 1 0.0000
155 ARTHRALGIA 3 0.0000
156 PAIN 4 0.0000
157 PERIPHERAL SWELLING 1 0.0000
158 TREMOR 1 0.0000
159 ABDOMINAL DISCOMFORT 1 0.0000
160 CEREBROVASCULAR ACCIDENT 1 0.0000
161 MYALGIA 1 0.0000
162 PYREXIA 2 0.0000
163 PRODUCT USE ISSUE 1 0.0000
164 ASTHENIA 2 0.0000
165 NAUSEA 4 0.0000
166 ERYTHEMA 1 0.0000
167 ABDOMINAL PAIN UPPER 1 0.0000
168 RASH 2 0.0000
169 WEIGHT INCREASED 1 0.0000
170 VOMITING 2 0.0000
171 FEELING ABNORMAL 1 0.0000
172 PNEUMONIA 1 0.0000
173 DRUG INEFFECTIVE 4 0.0000
174 OFF LABEL USE 2 0.0000
175 MALAISE 1 0.0000
176 DYSPNOEA 1 0.0000